NANOVIRICIDES, INC. Proceeds from Issuance of Private Placement
NANOVIRICIDES, INC. (NNVC) had Proceeds from Issuance of Private Placement of $9.20 million as of 2020-05-22, per its 10-K filed 2021-10-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2021-10-12
- NANOVIRICIDES, INC. proceeds from issuance of private placement for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- NANOVIRICIDES, INC. proceeds from issuance of private placement for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- NANOVIRICIDES, INC. proceeds from issuance of private placement for the quarter ending 2014-06-30 was $3.00.
- NANOVIRICIDES, INC. proceeds from issuance of private placement for the quarter ending 2014-03-31 was $18.91M.
- NANOVIRICIDES, INC. proceeds from issuance of private placement for fiscal 2016 was $0.00.
- NANOVIRICIDES, INC. proceeds from issuance of private placement for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- NANOVIRICIDES, INC. proceeds from issuance of private placement for fiscal 2014 was $28.60M.
- NANOVIRICIDES, INC. proceeds from issuance of private placement for fiscal 2013 was $0.00.
| Period end | Proceeds from Issuance of Private Placement | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month | Proceeds from Issuance of Private Placement 12 month as first filed | Proceeds from Issuance of Private Placement 77 month | Proceeds from Issuance of Private Placement 80 month | Proceeds from Issuance of Private Placement 83 month | Proceeds from Issuance of Private Placement 86 month | Proceeds from Issuance of Private Placement 89 month | Proceeds from Issuance of Private Placement 92 month | Proceeds from Issuance of Private Placement 95 month | Proceeds from Issuance of Private Placement 99 month | Proceeds from Issuance of Private Placement 101 month | Proceeds from Issuance of Private Placement 104 month | Proceeds from Issuance of Private Placement 107 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-05-22 | $9.20M 10-K · filed 2021-10-12 | ||||||||||||||||
| 2020-04-02 | $6.10M 10-K · filed 2021-10-12 | ||||||||||||||||
| 2016-06-30 | $0.00 10-K · filed 2016-09-16 | ||||||||||||||||
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-16 | $0.00 derived: sum of 2 quarters · filed 2016-09-16 | $0.00 10-K · filed 2016-09-16 | ||||||||||||||
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $0.00 10-Q · filed 2015-05-15 | |||||||||||||||
| 2014-12-31 | $0.00 10-Q · filed 2015-02-25 | ||||||||||||||||
| 2014-06-30 | $3.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-16 | $18.91M derived: sum of 2 quarters · filed 2016-09-16 | $18.91M derived: sum of 3 quarters · filed 2016-09-16 | $28.60M 10-K · filed 2016-09-16 | $28.60M 10-K · filed 2014-09-30 | ||||||||||||
| 2014-03-31 | $18.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $18.91M derived: sum of 2 quarters · filed 2015-05-15 | $28.60M 10-Q · filed 2015-05-15 | $28.60M derived: sum of 4 quarters · filed 2015-09-14 | $39.90M 10-Q · filed 2014-05-15 | ||||||||||||
| 2013-12-31 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-02-25 | $9.69M 10-Q · filed 2015-02-25 | $9.69M derived: sum of 3 quarters · filed 2015-09-14 | $9.69M derived: sum of 4 quarters · filed 2015-09-14 | $20.99M 10-Q · filed 2014-02-14 | ||||||||||||
| 2013-09-30 | $9.69M 10-Q/A · filed 2015-02-23 | $9.69M derived: sum of 2 quarters · filed 2015-09-14 | $9.69M derived: sum of 3 quarters · filed 2015-09-14 | $9.69M derived: sum of 4 quarters · filed 2015-09-14 | $20.99M 10-Q/A · filed 2013-11-18 | ||||||||||||
| 2013-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-14 | $0.00 derived: sum of 2 quarters · filed 2015-09-14 | $0.00 derived: sum of 3 quarters · filed 2015-09-14 | $0.00 10-K · filed 2015-09-14 | $11.30M 10-K/A · filed 2013-10-08 | ||||||||||||
| 2013-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-15 | $0.00 derived: sum of 2 quarters · filed 2014-05-15 | $0.00 10-Q · filed 2014-05-15 | $0.00 derived: sum of 4 quarters · filed 2015-02-23 | $11.30M 10-Q/A · filed 2013-05-20 | ||||||||||||
| 2012-12-31 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-02-14 | $0.00 10-Q · filed 2014-02-14 | $0.00 derived: sum of 3 quarters · filed 2015-02-23 | $0.00 derived: sum of 4 quarters · filed 2015-02-23 | $11.30M 10-Q/A · filed 2013-02-22 | ||||||||||||
| 2012-09-30 | $0.00 10-Q/A · filed 2013-11-18 | $0.00 derived: sum of 2 quarters · filed 2015-02-23 | $0.00 derived: sum of 3 quarters · filed 2015-02-23 | $0.00 derived: sum of 4 quarters · filed 2015-02-23 | $11.30M 10-Q · filed 2012-11-19 | ||||||||||||
| 2012-06-30 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-02-23 | $0.00 derived: sum of 2 quarters · filed 2015-02-23 | $0.00 derived: sum of 3 quarters · filed 2015-02-23 | $0.00 10-K · filed 2015-02-23 | $11.30M 10-K/A · filed 2012-10-26 | ||||||||||||
| 2012-03-31 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-05-20 | $0.00 derived: sum of 2 quarters · filed 2013-05-20 | $0.00 10-Q/A · filed 2013-05-20 | $0.00 derived: sum of 4 quarters · filed 2013-05-20 | $11.30M 10-Q · filed 2012-05-21 | ||||||||||||
| 2011-12-31 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-02-22 | $0.00 10-Q/A · filed 2013-02-22 | $0.00 derived: sum of 3 quarters · filed 2013-02-22 | $0.00 derived: sum of 4 quarters · filed 2013-02-22 | $11.30M 10-Q · filed 2012-02-14 | ||||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-19 | $0.00 derived: sum of 2 quarters · filed 2012-11-19 | $0.00 derived: sum of 3 quarters · filed 2012-11-19 | $0.00 derived: sum of 4 quarters · filed 2012-11-19 | $11.30M 10-Q/A · filed 2011-12-12 | ||||||||||||
| 2011-06-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-26 | $0.00 derived: sum of 2 quarters · filed 2012-10-26 | $0.00 derived: sum of 3 quarters · filed 2012-10-26 | $0.00 10-K/A · filed 2012-10-26 | |||||||||||||
| 2011-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-21 | $0.00 derived: sum of 2 quarters · filed 2012-05-21 | $0.00 10-Q · filed 2012-05-21 | ||||||||||||||
| 2010-12-31 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-02-14 | $0.00 10-Q · filed 2012-02-14 | |||||||||||||||
| 2010-09-30 | $0.00 10-Q/A · filed 2011-12-12 | ||||||||||||||||
| 2010-06-30 | $1.43M 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |